185 related articles for article (PubMed ID: 17159220)
21. Novel hemin binding domains in the Corynebacterium diphtheriae HtaA protein interact with hemoglobin and are critical for heme iron utilization by HtaA.
Allen CE; Schmitt MP
J Bacteriol; 2011 Oct; 193(19):5374-85. PubMed ID: 21803991
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a Propionibacterium acnes Surface Protein as a Fibrinogen-Binding Protein.
Grange PA; Raingeaud J; Morelle W; Marcelin AG; Calvez V; Dupin N
Sci Rep; 2017 Jul; 7(1):6428. PubMed ID: 28743910
[TBL] [Abstract][Full Text] [Related]
23. Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci.
Brandt ER; Hayman WA; Currie B; Pruksakorn S; Good MF
Vaccine; 1997 Nov; 15(16):1805-12. PubMed ID: 9364687
[TBL] [Abstract][Full Text] [Related]
24. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus.
Hayman WA; Brandt ER; Relf WA; Cooper J; Saul A; Good MF
Int Immunol; 1997 Nov; 9(11):1723-33. PubMed ID: 9418133
[TBL] [Abstract][Full Text] [Related]
25. Phenotype and Antimicrobial Activity of Th17 Cells Induced by Propionibacterium acnes Strains Associated with Healthy and Acne Skin.
Agak GW; Kao S; Ouyang K; Qin M; Moon D; Butt A; Kim J
J Invest Dermatol; 2018 Feb; 138(2):316-324. PubMed ID: 28864077
[TBL] [Abstract][Full Text] [Related]
26. Evidence for diversity within Propionibacterium acnes: a comparison of the T-cell stimulatory activity of isolates from inflammatory acne, endocarditis and the laboratory.
Jappe U; Boit R; Farrar MD; Ingham E; Sandoe J; Holland KT
J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):450-4. PubMed ID: 15196160
[TBL] [Abstract][Full Text] [Related]
27. Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients.
Webster GF; Indrisano JP; Leyden JJ
J Invest Dermatol; 1985 Jun; 84(6):496-500. PubMed ID: 3158714
[TBL] [Abstract][Full Text] [Related]
28. [Physiopathological mechanisms in acne vulgaris].
Vignale RA; Lasalvia E; Assandri J
Med Cutan Ibero Lat Am; 1981; 9(2):79-86. PubMed ID: 6457226
[TBL] [Abstract][Full Text] [Related]
29. Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris.
Liu PF; Hsieh YD; Lin YC; Two A; Shu CW; Huang CM
Curr Drug Metab; 2015; 16(4):245-54. PubMed ID: 26264195
[TBL] [Abstract][Full Text] [Related]
30. [Leukocyte migration inhibition factor in acne vulgaris].
Vignale RA; Lasalvia E; Paciel J
Med Cutan Ibero Lat Am; 1980; 8(4-6):101-3. PubMed ID: 6456387
[TBL] [Abstract][Full Text] [Related]
31. Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients.
Kistowska M; Meier B; Proust T; Feldmeyer L; Cozzio A; Kuendig T; Contassot E; French LE
J Invest Dermatol; 2015 Jan; 135(1):110-118. PubMed ID: 25010142
[TBL] [Abstract][Full Text] [Related]
32. Antigenic diversity within a family of M proteins from group A streptococci: evidence for the role of frameshift and compensatory mutations.
Relf WA; Martin DR; Sriprakash KS
Gene; 1994 Jun; 144(1):25-30. PubMed ID: 7517905
[TBL] [Abstract][Full Text] [Related]
33. The Anti-Inflammatory Activities of Propionibacterium acnes CAMP Factor-Targeted Acne Vaccines.
Wang Y; Hata TR; Tong YL; Kao MS; Zouboulis CC; Gallo RL; Huang CM
J Invest Dermatol; 2018 Nov; 138(11):2355-2364. PubMed ID: 29964032
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte transformation in subjects with nodulo cystic acne.
Puhvel SM; Amirian D; Weintraub J; Reisner RM
Br J Dermatol; 1977 Aug; 97(2):205-11. PubMed ID: 143951
[TBL] [Abstract][Full Text] [Related]
35. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
[TBL] [Abstract][Full Text] [Related]
36. [Occurrence and levels of serum antibodies against Propionibacterium antigens in persons of various ages].
Kałuzewski S; Kasprowicz A
Med Dosw Mikrobiol; 1987; 39(3):137-42. PubMed ID: 2959828
[No Abstract] [Full Text] [Related]
37. Acne from an immunological perspective.
Puhvel SM
Cutis; 1976 Mar; 17(3):502-6. PubMed ID: 138543
[TBL] [Abstract][Full Text] [Related]
38. Antibodies against extractable components from Propionibacterium acnes in humans with and without acne vulgaris.
Dalen A; Hellgren L; Iversen OJ; Vincent J
Arch Dermatol Res; 1980; 269(3):253-9. PubMed ID: 6453560
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory acne represents hypersensitivity to Propionibacterium acnes.
Webster GF
Dermatology; 1998; 196(1):80-1. PubMed ID: 9557234
[TBL] [Abstract][Full Text] [Related]
40. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
